The European Medicines Agency’s (EMA) Committee for Medicinal Use Products (CHMP) recently recommended approval of six new biosimilars.

A research centre specialising in the financial reforms introduced by Manmohan Singh would be established at Bangalore ...

Biocon Ltd is quoting at Rs 352.1, up 1.63% on the day as on 12:49 IST on the NSE. The stock is up 42.35% in last one year as compared to a 9.51% jump in NIFTY and a 36.31% jump in the Nifty Pharma ...

Industry leaders mourn the death of former PM Manmohan Singh, praising his role in shaping modern India and his contributions ...

Adani Ports, M&M lead gainers; Titan, Asian Paints top losers in a volatile market session. Check the full list of buzzing ...

Biocon’s stock jumped on December 24 after the United States Food and Drug Administration (USFDA) and the European Union ...

At the CXO-Entrepreneurs Alumni Meet 2024, hosted by MIT World Peace University (MIT-WPU), thought leaders and ...

Bengaluru: Biocon has received an Establishment Inspection Report (EIR) with a Voluntary Action Indicated (VAI) status from ...

Shares of the biopharma major rose earlier today when it announced that its European partner, Zentiva, received a procedure ...

Biocon rallied 4.63% to Rs 344.80 after it received an establishment inspection report (EIR) with a voluntary action indicated (VAI) status from the US drug regulator, for API facility located at ...

The approval is for the generic versions of Victoza to treat Type-2 Diabetes and Saxenda used in the treatment of weight ...

Biocon Ltd, in collaboration with Zentiva, has obtained EU approval for the complex formulation Liraglutide, a generic ...